Your browser doesn't support javascript.
loading
Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections.
Shorr, Andrew F; Lodise, Thomas P; Corey, G Ralph; De Anda, Carisa; Fang, Edward; Das, Anita F; Prokocimer, Philippe.
Affiliation
  • Shorr AF; Pulmonary and Critical Care Medicine, Washington Hospital Center, Washington, DC, USA.
  • Lodise TP; Albany College of Pharmacy and Health Sciences, Albany, New York, USA.
  • Corey GR; Duke University Health System, Durham, North Carolina, USA.
  • De Anda C; Cubist Pharmaceuticals, San Diego, California, USA.
  • Fang E; Cubist Pharmaceuticals, San Diego, California, USA.
  • Das AF; InClin, Inc., San Mateo, California, USA.
  • Prokocimer P; Cubist Pharmaceuticals, San Diego, California, USA philippe.prokocimer@cubist.com.
Antimicrob Agents Chemother ; 59(2): 864-71, 2015 Feb.
Article in En | MEDLINE | ID: mdl-25421472
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tetrazoles / Staphylococcal Skin Infections / Oxazolidinones / Acetamides / Anti-Bacterial Agents Type of study: Clinical_trials Limits: Female / Humans / Male Language: En Journal: Antimicrob Agents Chemother Year: 2015 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tetrazoles / Staphylococcal Skin Infections / Oxazolidinones / Acetamides / Anti-Bacterial Agents Type of study: Clinical_trials Limits: Female / Humans / Male Language: En Journal: Antimicrob Agents Chemother Year: 2015 Type: Article Affiliation country: United States